Author

Chad B. Sussman

Institutions: University of Maryland Medical Center, Harvard University

Observed institutions: University of Maryland, Baltimore, University of Maryland Medical Center, Harvard University

ORCID: 0000-0003-4907-0926

Observed ORCID: 0000-0003-4907-0926

OpenAlex ID: A5033923930

Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al. · Cancer Prevention Research · 20

Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2024 · Laura Wollborn, James W. Webber, et al. · Cancer Epidemiology Biomarkers & Prevention · 3

Acute Amnesia Resulting in Complete Relief of Pain, Depression, and Anxiety

2025 · Jacqueline Ohmura, Chad B. Sussman, et al. · Journal of Pain and Symptom Management · 1

Brief Report: Androgen Receptor Expression Is Associated With Male Predominance in Thymic Neuroendocrine Neoplasms

2026 · Christopher S. Nabel, Chad B. Sussman, et al. · JTO Clinical and Research Reports

Case Report: Pathologic complete response in a patient with simultaneous diagnoses of resectable NSCLC and myeloid neoplasm with PDGFRA rearrangement treated with concurrent neoadjuvant chemoimmunotherapy and imatinib: translating clinical trial data to real-world practice

2025 · Chad B. Sussman, Minal Shah, et al. · Frontiers in Oncology

Figure S1 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Figure S3 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Figure S2 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Data from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Table S3 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Table S1 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Figure S4 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Raw data from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Table S2 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer

2025 · Laura Wollborn, James W. Webber, et al.

Data from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al.

Data from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al.

Supplemental Table 2 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al.

Supplemental Table 3 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al.

Supplemental Table 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al.

Supplemental Figure 1 from Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable Ovarian Cancer Screening Test

2024 · Stephanie Alimena, Briana Joy K. Stephenson, et al.

Abstract B044: Serum miRNA expression in ovarian cancer patients is independent of histological subtype and FIGO stage

2024 · Laura Wollborn, James W. Webber, et al. · Cancer Research

Abstract PR001: Assessing differences in miRNA profiles by race and ethnicity: Implications for creating an equitable ovarian cancer early detection test

2023 · Stephanie Alimena, James Webber, et al. · Cancer Epidemiology Biomarkers & Prevention

Thermodynamic Investigations of Chiral Selection with Bile Salt Micelles

2019 · Chad B. Sussman · Bucknell Digital Commons (Bucknell University)

Works count: 23

Citation count: 24

H-index: 2

I10-index: 1